Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Short

Showing results (141-150 of 203) with videos related to

Pageof 21
Sort By:
Radiation Oncology (London, England)|June 3, 2014
Cytokine levels as biomarkers of radiation fibrosis in patients treated with breast radiotherapyCharlotte B Westbury, Joanne Haviland, Sue Davies, et al.
Neuro-Oncology Advances|December 22, 2023
Genomic landscape and actionable mutations of brain metastases derived from non-small cell lung cancer: A systematic reviewLily J Andrews, Zak A Thornton, Ruqiya Saleh, et al.
Clinical and Translational Radiation Oncology|March 30, 2018
PARADIGM-2: Two parallel phase I studies of olaparib and radiotherapy or olaparib and radiotherapy plus temozolomide in patients with newly diagnosed glioblastoma, with treatment stratified by MGMT statusBen Fulton, Susan C Short, Allan James, et al.
International Journal of Radiation Oncology, Biology, Physics|December 20, 2017
Systematic Review of Synthetic Computed Tomography Generation Methodologies for Use in Magnetic Resonance Imaging-Only Radiation TherapyEmily Johnstone, Jonathan J Wyatt, Ann M Henry, et al.
Frontiers in Oncology|April 2, 2019
FGFR1 Expression and Role in Migration in Low and High Grade Pediatric GliomasNaomi Egbivwie, Julia V Cockle, Matthew Humphries, et al.
Journal of Environmental Management|August 11, 2025
Optimizing woody fuel treatments to reduce wildfire risk to sagebrush ecosystems in the Great Basin of the western USMichelle A Day, Claire M Tortorelli, Lisa M Ellsworth, et al.
BMC Cancer|January 15, 2024
A randomised phase II trial of temozolomide with or without cannabinoids in patients with recurrent glioblastoma (ARISTOCRAT): protocol for a multi-centre, double-blind, placebo-controlled trialDivyalakshmi Bhaskaran, Joshua Savage, Amit Patel, et al.
Molecular Oncology|December 16, 2014
Prediction of clinical outcome in glioblastoma using a biologically relevant nine-microRNA signatureJosie Hayes, Helene Thygesen, Charlotte Tumilson, et al.
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|August 28, 2002
High-dose methylprednisolone for acute closed spinal cord injury--only a treatment optionH Hugenholtz, D E Cass, M F Dvorak, et al.
Medical Physics|November 6, 2014
Benchmarking of a treatment planning system for spot scanning proton therapy: comparison and analysis of robustness to setup errors of photon IMRT and proton SFUD treatment plans of base of skull meningiomaR Harding, P Trnková, S J Weston, et al.
Pageof 21

Showing results (141-150 of 203) with videos related to

Sort By:
Pageof 21
Radiation Oncology (London, England)|June 3, 2014
Cytokine levels as biomarkers of radiation fibrosis in patients treated with breast radiotherapyCharlotte B Westbury, Joanne Haviland, Sue Davies, et al.
Neuro-Oncology Advances|December 22, 2023
Genomic landscape and actionable mutations of brain metastases derived from non-small cell lung cancer: A systematic reviewLily J Andrews, Zak A Thornton, Ruqiya Saleh, et al.
Clinical and Translational Radiation Oncology|March 30, 2018
PARADIGM-2: Two parallel phase I studies of olaparib and radiotherapy or olaparib and radiotherapy plus temozolomide in patients with newly diagnosed glioblastoma, with treatment stratified by MGMT statusBen Fulton, Susan C Short, Allan James, et al.
International Journal of Radiation Oncology, Biology, Physics|December 20, 2017
Systematic Review of Synthetic Computed Tomography Generation Methodologies for Use in Magnetic Resonance Imaging-Only Radiation TherapyEmily Johnstone, Jonathan J Wyatt, Ann M Henry, et al.
Frontiers in Oncology|April 2, 2019
FGFR1 Expression and Role in Migration in Low and High Grade Pediatric GliomasNaomi Egbivwie, Julia V Cockle, Matthew Humphries, et al.
Journal of Environmental Management|August 11, 2025
Optimizing woody fuel treatments to reduce wildfire risk to sagebrush ecosystems in the Great Basin of the western USMichelle A Day, Claire M Tortorelli, Lisa M Ellsworth, et al.
BMC Cancer|January 15, 2024
A randomised phase II trial of temozolomide with or without cannabinoids in patients with recurrent glioblastoma (ARISTOCRAT): protocol for a multi-centre, double-blind, placebo-controlled trialDivyalakshmi Bhaskaran, Joshua Savage, Amit Patel, et al.
Molecular Oncology|December 16, 2014
Prediction of clinical outcome in glioblastoma using a biologically relevant nine-microRNA signatureJosie Hayes, Helene Thygesen, Charlotte Tumilson, et al.
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|August 28, 2002
High-dose methylprednisolone for acute closed spinal cord injury--only a treatment optionH Hugenholtz, D E Cass, M F Dvorak, et al.
Medical Physics|November 6, 2014
Benchmarking of a treatment planning system for spot scanning proton therapy: comparison and analysis of robustness to setup errors of photon IMRT and proton SFUD treatment plans of base of skull meningiomaR Harding, P Trnková, S J Weston, et al.
Pageof 21